. These open reading frames encode viral regulatory proteins that play a key role in orchestrating the complex pattern of viral gene expression observed in lentivirusinfected cells (2-4, 6, 10, 17, 21, 26).
Lentiviruses form a retroviral subfamily characterized by the ability to induce chronic, degenerative diseases marked by high levels of latently infected cells (5, 8) . Phylogenetic analysis suggests that this retroviral family can be divided into two subgroups, here termed primate lentiviruses and ungulate lentiviruses (23) . The prototypic primate lentivirus is the highly pathogenic human immunodeficiency virus type 1 (HIV-1), while the prototypic ungulate lentivirus is visna virus, a pathogen of sheep and goats. Although HIV-1 and visna virus share only limited primary sequence homology, they do share the characteristic lentivirus genomic organization, marked particularly by the presence of additional open reading frames between the viral pol and env genes (2, 17, 22) . These open reading frames encode viral regulatory proteins that play a key role in orchestrating the complex pattern of viral gene expression observed in lentivirusinfected cells (2-4, 6, 10, 17, 21, 26) .
Both HIV-1 and visna virus have been shown to encode a nuclear regulatory protein, termed Rev, that is required for the expression of the unspliced and singly spliced mRNAs that encode the viral structural proteins (6, 21, 24) . Although the mechanism of action of these Rev proteins remains uncertain, both appear to activate the nuclear export of incompletely spliced viral mRNA species that are otherwise sequestered within the nucleus of expressing cells (7, 14, 24) . While both visna virus and HIV-1 Rev act via structured RNA target sequences, termed Rev response elements (RREs), located in the viral envelope gene, neither Rev protein is able to functionally interact with the RRE of the other virus in vivo (14, 24) .
Mutational dissection of the HIV-1 Rev protein has revealed the existence of two protein domains that appear comparable to the "binding domain" and "activation domain" described for several eukaryotic transcription factors (20) . The RNA binding domain of Rev, located toward the protein N terminus, is an approximately 40-amino-acid (aa) sequence element encompassing a highly basic core that * Corresponding author. displays sequence homology to the arginine-rich RNA binding motif (11) (Fig. 1) . Mutations within this domain affect the binding of Rev to the RRE and result in a recessive negative phenotype in vivo (9, 12, 13, 19) . A second functional domain, located toward the C terminus of Rev, is characterized by an approximately 10-aa leucine-rich motif. Mutations within this motif have no effect on the interaction of Rev with the RRE in vitro yet result in a dominant negative phenotype in vivo (9, 12, 13, 16, 19, 25) . It has therefore been proposed that this motif represents a site of interaction with a cellular protein(s) that regulates RNA fate within the nucleus (12) .
Alignment of the primary amino acid sequence of the HIV-1 and visna virus Rev proteins reveals minimal sequence identity. However, the two protein sequence elements defined above as critical for HIV-1 Rev function, i.e., the basic motif and the leucine motif, do appear to be moderately conserved (Fig. 1) . To test the hypothesis that these lentivirus regulatory proteins have maintained a similar functional organization through evolution, we asked whether hybrid Rev proteins bearing the basic domain of one Rev protein joined to the leucine domain of the other Rev protein would be functional in vivo. Chimeric proteins were constructed using the M9 mutant of HIV-1 Rev, which contains a missense mutation at aa positions 67 and 68 (SA-*DL) that introduces a BglII site (12) , and a mutant of visna Rev that contains a missense mutation at aa positions 98 to 100 (FYP-*LDL) that introduces a BamHI site (Fig. 1 (3, 12) were aligned by computer to maximize the incidence of amino acid identities and of conservative changes. The basic domain and the leucine domain fulfill essential but distinct functions in the HIV-1 Rev protein (see text for details). Exon junctions are indicated by black triangles. PNME-C'). The pcRev and pcL plasmids express the wildtype HIV-1 and visna virus Rev proteins, respectively (14, 24) .
To assay the in vivo activity of these chimeric proteins, we used previously described transient transfection assays for the detection of HIV-1 or visna virus Rev activity (14, 24 (Fig. 2, lanes 3 and 7) . Conversely, the hybrid protein bearing the basic domain of HIV-1 Rev and the putative leucine domain of visna virus Rev proved fully active in the HIV-1 context but was inactive when tested on the visna virus pEnv indicator construct (Fig. 2, lanes 4 and  8) . These results therefore demonstrate that the N-terminal domains of HIV-1 and visna virus Revs are fully sufficient to confer RNA sequence specificity, while both C-terminal protein domains are able to provide similar or identical activation functions.
To address whether the putative leucine motif of visna virus Rev indeed represented the core of an activation domain, we next constructed a series of mutants targeted to this protein sequence (Table 1) . From the precedent of HIV-1 Rev (12) , we predicted that these visna virus Rev mutants might display a dominant negative phenotype in vivo. The ability of these' mutant visna virus Rev proteins to activate visna virus structural protein expression was first tested with the pEnv indicator construct. As shown in Fig.  3A , the L-M1 and L-M2 mutants retained partial Rev activity, while the L-M3 and L-M4 missense mutants failed to induce-any detectable visna virus Env protein expression.
The more extensive LAM14 mutant also proved phenotypically inactive in this assay (data not shown).
We next assayed the ability of these mutant visna virus Rev proteins to inhibit the wild-type visna virus Rev protein in trans. In this experiment (Fig. 3B) , the pEnv construct was cotransfected with a small amount of the wild-type visna virus Rev expression plasmid pcL together with an 18-fold molar excess of each mutant visna virus Rev expression plasmid. Under similar conditions, HIV-1 Rev mutants bearing a defective leucine motif have been shown to inhibit wild-type HIV-1 Rev activity by >90% (12) . As predicted, the pL-M1 and pL-M2 mutants, which displayed partial HIV-1 RRE The location of mutations is given using the amino acid coordinates presented in Fig. 1 . Vectors encoding mutant forms of the visna virus Rev protein were derived from the previously described visna virus Rev expression plasmid pcL (24) using the polymerase chain reaction (18) . Flanking primers spanned unique restriction enzyme sites located in the cytomegalovirus immediate-early promoter (Sacl) or in the 3' non-coding region present in the vector (XhoI). The polymerase chain reaction primers utilized for mutagenesis contained mismatches that introduced the indicated mutations. These primers also introduced unique restriction enzyme sites into the visna virus rev gene (BgIII in L-M1, L-M2, and L-M4; NheI in L-M3). The deletion mutant pLAM14 was constructed by inserting a SacI-to-BgIII rev gene fragment derived from pL-M1 in place of the similar SacI-to-Bg1II fragment present in pL-M4. Biological activity of these visna virus Rev mutants was assayed as described in the text: +, fully active; +, partially active; -, inactive.
activity in vivo (Fig. 3A) 4A and data not shown) .
One possible explanation for the lack of a marked transdominant negative phenotype is that the mutations introduced into visna virus rev resulted in reduced expression of the mutant proteins. As an initial test of this hypothesis, we used immunoprecipitation to compare the level of synthesis of the wild-type and mutant visna virus Rev proteins in transfected cell cultures (Fig. 3C) . This experiment suggested that the level of expression of the various missense mutants of visna virus Rev was comparable. Of note, immunofluorescence analysis of transfected cultures revealed that the phenotypically negative L-M3 protein was appropriately localized to the cell nucleus (24) and appeared to be expressed at levels comparable to those of the wild-type visna virus Rev protein (data not shown). Therefore, it does not appear that the lack of a marked trans-dominant negative phenotype evidenced by these negative mutants of visna virus Rev can be explained by low expression.
The data presented in Fig. 2 showed that an HIV-1 Rev protein lacking the essential C-terminal leucine motif could be rescued by fusion to an apparently similar protein motif present within the visna virus Rev protein. However, mutation of this same motif within the context of the full-length visna virus Rev trans activator resulted in proteins that either retained partial activity (L-M1 and L-M2) or displayed only weak trans dominance (L-M3 and L-M4). We therefore next examined the role of the leucine motif in the context of the hybrid Rev proteins described above. We have described elsewhere a trans-dominant negative mutant of HIV-1 Rev, termed M32, in which three leucines present in the leucine motif have been changed to alanine (15) . This same mutation was introduced into pL/Rev to give the pL/Rev-M32 expression plasmid. Similarly, the M3 missense mutation (Table 1) (1) with the indicator construction pEnv together with either the negative control plasmid pBC12/CMV (14) (Neg) or the indicated wild-type or mutant visna virus Rev expression vector. Rev activity, detected as expression of the visna virus envelope proteins, was assayed by immunoprecipitation as described in the legend to Fig. 2. (B) COS cell cultures were transfected (1) with 25 ng of pEnv and (with the exception of negative control lane 6) 25 ng of pcL. Cultures were also transfected with 450 ng of the indicated visna virus Rev mutant expression plasmid or with the negative control plasmid pBC12/CMV. If the mutants exhibit a dominant negative phenotype, then inhibition of the expression of the visna virus Env protein is predicted (12) . Env expression was assayed by immunoprecipitation as described in the legend to Fig. 2 (Fig. 4) . However, similar leucine motif mutations, when introduced into the full-length visna virus Rev protein, resulted in only a weakly dominant negative phenotype (Fig. 3) . This phenotype could reflect an impaired ability to bind to the visna virus RRE, a reduced ability to form functional Rev multimers (13, 19) (Fig. 4A ). This result therefore raises the possibility of using the pL/Rev-M32 construct to generate transgenic sheep or goats resistant to visna virus and possibly also to closely related ungulate lentiviruses such as caprine arthritis-encephalitis virus. These diseases represent economically important pathogens of domestic sheep and goats (8) , so resistant breeds could be of significant value. In addition, this might well represent a useful model to test the hypothesis that trans-dominant mutants of essential viral regulatory proteins could be useful in protecting cells, and hence whole animals, against the pathogenic effects resulting from specific viral infections.
